Leukemia - Table of Contents alert Volume 27 Issue 7

Advertisement BD FACSCanto™ II: Timeless reliability.  With its proven reliability and consistency, the BD FACSCanto™ II lets you keep work flowing so clinicians can more confidently deliver patient care. For over 40 years we've been making flow cytometry solutions that help make your job easier, your workflow more efficient, and your results more reliable. bdbiosciences.com/go/canto TABLE OF CONTENTS Volume 27, Issue 7 (July 2013) In this issue Spotlight Review Review Original Articles Letters To The Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Follow on Twitter Subscribe Advertisement Naturejobs presents the: Naturejobs Career Expo September 19, 2013 The Business Design Centre, London, UK  Click here for more information or to register for this conference today! Spotlight Review Top SPOTLIGHT ON CLONAL EVOLUTION IN LEUKEMIAS An evolutionary perspective on chronic myelomonocytic leukemia R Itzykson and E Solary Leukemia 2013 27: 1441-1450; advance online publication, April 5, 2013; 10.1038/leu.2013.100 Abstract | Full Text Review Top Novel therapies for children with acute myeloid leukaemia A S Moore, P R Kearns, S Knapper, A D J Pearson and C M Zwaan Leukemia 2013 27: 1451-1460; advance online publication, April 8, 2013; 10.1038/leu.2013.106 Abstract | Full Text Original Articles Top ACUTE LEUKEMIAS The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis H Osaki, V Walf-Vorderwülbecke, M Mangolini, L Zhao, S J Horton, G Morrone, J J Schuringa, J de Boer and O Williams Leukemia 2013 27: 1461-1468; advance online publication, February 13, 2013; 10.1038/leu.2013.42 Abstract | Full Text The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells T Chen, Z Meng, Y Gan, X Wang, F Xu, Y Gu, X Xu, J Tang, H Zhou, X Zhang, X Gan, C Van Ness, G Xu, L Huang, X Zhang, Y Fang, J Wu, S Zheng, J Jin, W Huang and R Xu Leukemia 2013 27: 1469-1478; advance online publication, January 11, 2013; 10.1038/leu.2013.8 Abstract | Full Text A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse S Park, N Chapuis, F Saint Marcoux, C Recher, T Prebet, P Chevallier, J-Y Cahn, T Leguay, P Bories, F Witz, T Lamy, P Mayeux, C Lacombe, C Demur, J Tamburini, A Merlat, R Delepine, N Vey, F Dreyfus, M C Béné, N Ifrah and D Bouscary GOELAMS (Groupe Ouest Est d’Etude des Leucémies aiguës et Autres Maladies du Sang) Leukemia 2013 27: 1479-1486; advance online publication, January 16, 2013; 10.1038/leu.2013.17 Abstract | Full Text C/EBPα and MYB regulate FLT3 expression in AML G Volpe, D S Walton, W Del Pozzo, P Garcia, E Dassé, L P O'Neill, M Griffiths, J Frampton and S Dumon Leukemia 2013 27: 1487-1496; advance online publication, January 23, 2013; 10.1038/leu.2013.23 Abstract | Full Text High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation G M Marshall, L Dalla Pozza, R Sutton, A Ng, H A de Groot-Kruseman, V H van der Velden, N C Venn, H van den Berg, E S J M de Bont, R Maarten Egeler, P M Hoogerbrugge, G J L Kaspers, M B Bierings, E van der Schoot, J van Dongen, T Law, S Cross, H Mueller, V de Haas, M Haber, T Révész, F Alvaro, R Suppiah, M D Norris and R Pieters Leukemia 2013 27: 1497-1503; advance online publication, February 14, 2013; 10.1038/leu.2013.44 Abstract | Full Text MYELODYSPLASIAS Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes M M Patnaik, E Padron, R R LaBorde, T L Lasho, C M Finke, C A Hanson, J M Hodnefield, R A Knudson, R P Ketterling, A Al-kali, A Pardanani, N A Ali, R S Komroji and A Tefferi Leukemia 2013 27: 1504-1510; advance online publication, March 27, 2013; 10.1038/leu.2013.88 Abstract | Full Text CHRONIC MYELOPROLIFERATIVE NEOPLASIAS Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib F Efficace, M Baccarani, M Breccia, F Cottone, G Alimena, G L Deliliers, C Baratè, G Specchia, R Di Lorenzo, L Luciano, D Turri, B Martino, F Stagno, M Dabusti, M Bergamaschi, P Leoni, M P Simula, L Levato, C Fava, D Veneri, S Sica, A Rambaldi, G Rosti, M Vignetti and F Mandelli Leukemia 2013 27: 1511-1519; advance online publication, February 18, 2013; 10.1038/leu.2013.51 Abstract | Full Text Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients S Mustjoki, J Richter, G Barbany, H Ehrencrona, T Fioretos, T Gedde-Dahl, B T Gjertsen, R Hovland, S Hernesniemi, D Josefsen, P Koskenvesa, I Dybedal, B Markevärn, T Olofsson, U Olsson-Strömberg, K Rapakko, S Thunberg, L Stenke, B Simonsson, K Porkka and H Hjorth-Hansen for the Nordic CML Study Group (NCMLSG) Leukemia 2013 27: 1520-1526; advance online publication, January 18, 2013; 10.1038/leu.2013.19 Abstract | Full Text IMMUNOLOGY IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect M Couturier, B Lamarthée, J Arbez, J-C Renauld, C Bossard, F Malard, F Bonnefoy, M Mohty, S Perruche, P Tiberghien, P Saas and B Gaugler Leukemia 2013 27: 1527-1537; advance online publication, February 12, 2013; 10.1038/leu.2013.39 Abstract | Full Text Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant G Weber, U Gerdemann, I Caruana, B Savoldo, N F Hensel, K R Rabin, E J Shpall, J J Melenhorst, A M Leen, A J Barrett and C M Bollard Leukemia 2013 27: 1538-1547; advance online publication, March 1, 2013; 10.1038/leu.2013.66 Abstract | Full Text ONCOGENES, FUSION GENES AND TUMOR SUPPRESSOR GENES Notch signaling in acute promyelocytic leukemia N R Grieselhuber, J M Klco, A M Verdoni, T Lamprecht, S M Sarkaria, L D Wartman and T J Ley Leukemia 2013 27: 1548-1557; advance online publication, March 4, 2013; 10.1038/leu.2013.68 Abstract | Full Text MYELOMA Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 L Mirandola, L Apicella, M Colombo, Y Yu, D G Berta, N Platonova, E Lazzari, M Lancellotti, G Bulfamante, E Cobos, M Chiriva-Internati and R Chiaramonte Leukemia 2013 27: 1558-1566; advance online publication, January 28, 2013; 10.1038/leu.2013.27 Abstract | Full Text Letters To The Editor Top Nilotinib shows prolonged intracellular accumulation upon pulse-exposure: a novel mechanism for induction of apoptosis in CML cells M-C Wagner, M Dziadosz, J V Melo, F Heidel, T Fischer and D B Lipka Leukemia 2013 27: 1567-1570; advance online publication, December 12, 2012; 10.1038/leu.2012.364 Full Text Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations Open M Li, L Jones, C Gaillard, M Binnewies, R Ochoa, E Garcia, V Lam, G Wei, W Yang, C Lobe, M Hermiston, E Passegué and S C Kogan Leukemia 2013 27: 1570-1573; advance online publication, January 16, 2013; 10.1038/leu.2013.15 Full Text Landmark analysis of DNMT3A mutations in hematological malignancies A Roller, V Grossmann, U Bacher, F Poetzinger, S Weissmann, N Nadarajah, L Boeck, W Kern, C Haferlach, S Schnittger, T Haferlach and A Kohlmann Leukemia 2013 27: 1573-1578; advance online publication, March 1, 2013; 10.1038/leu.2013.65 Full Text BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia S Agatheeswaran, S Singh, S Biswas, G Biswas, N Chandra Pattnayak and S Chakraborty Leukemia 2013 27: 1578-1580; advance online publication, November 23, 2012; 10.1038/leu.2012.339 Full Text Decitabine facilitates the generation and immunosuppressive function of regulatory γδT cells derived from human peripheral blood mononuclear cells Y Hu, Q Cui, Y Gu, L Sheng, K Wu, J Shi, Y Tan, H Fu, L Liu, S Fu, X Yu and H Huang Leukemia 2013 27: 1580-1585; advance online publication, November 29, 2012; 10.1038/leu.2012.345 Full Text Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia Open Y L Liu, S Y Lensing, Y Yan, T M Cooper, M L Loh and P D Emanuel Leukemia 2013 27: 1585-1588; advance online publication, February 18, 2013; 10.1038/leu.2013.49 Full Text GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations M Perugini, D G Iarossi, C H Kok, N Cummings, S M Diakiw, A L Brown, S Danner, P Bardy, L Bik To, A H Wei, I D Lewis and R J D'Andrea Leukemia 2013 27: 1588-1592; advance online publication, November 28, 2012; 10.1038/leu.2012.346 Full Text Murine mantle cell lymphoma model cell line M R Smith, I Joshi, J Pei, M Slifker, F Jin, J R Testa and T Al-Saleem Leukemia 2013 27: 1592-1594; advance online publication, December 28, 2012; 10.1038/leu.2012.370 Full Text The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients C Kellner, E A Zhukovsky, A Pötzke, M Brüggemann, A Schrauder, M Schrappe, M Kneba, R Repp, A Humpe, M Gramatzki and M Peipp Leukemia 2013 27: 1595-1598; advance online publication, January 1, 2013; 10.1038/leu.2012.373 Full Text STAT3 mutations are highly specific for large granular lymphocytic leukemia A Fasan, W Kern, V Grossmann, C Haferlach, T Haferlach and S Schnittger Leukemia 2013 27: 1598-1600; advance online publication, December 4, 2012; 10.1038/leu.2012.350 Full Text Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia A J Ramsay, D Rodríguez, N Villamor, A Kwarciak, J R Tejedor, J Valcárcel, A López-Guillermo, A Martínez-Trillos, X S Puente, E Campo, C López-Otín and V Quesada Leukemia 2013 27: 1600-1603; advance online publication, November 28, 2012; 10.1038/leu.2012.344 Full Text Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia N C Correia, K Durinck, A P Leite, M Ongenaert, P Rondou, F Speleman, F J Enguita and J T Barata Leukemia 2013 27: 1603-1606; advance online publication, March 1, 2013; 10.1038/leu.2013.63 Full Text All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene S Strehl, M König, H Boztug, B W Cooper, K Suzukawa, S-J Zhang, H-Y Chen, A Attarbaschi and M N Dworzak Leukemia 2013 27: 1606-1610; advance online publication, December 28, 2012; 10.1038/leu.2012.371 Full Text A G polymorphism in the CRBN gene acts as a biomarker of response to treatment with lenalidomide in low/int-1 risk MDS without del(5q) V Sardnal, A Rouquette, S Kaltenbach, C Bally, V Chesnais, C Leschi, L Ades, V Santini, S Park, A Toma, P Fenaux, F Dreyfus, M Fontenay and O Kosmider Leukemia 2013 27: 1610-1613; advance online publication, February 26, 2013; 10.1038/leu.2013.59 Full Text Loss of Tcf7 diminishes hematopoietic stem/progenitor cell function G Huls, J van Es, H Clevers, G de Haan and R van Os Leukemia 2013 27: 1613-1614; advance online publication, December 5, 2012; 10.1038/leu.2012.354 Full Text Corrigendum Top Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium A Martino, D Campa, G Buda, J Sainz, R García-Sanz, K Jamroziak, R M Reis, N Weinhold, M Jurado, R Ríos, Z Szemraj-Rogucka, H Marques, J Szemraj, A Stein, R Kumar, E Orciuolo, F Gemignani, S Landi, H Goldschmidt, M Petrini, C Dumontet, F Canzian and A M Rossi Leukemia 2013 27: 1615-1616; 10.1038/leu.2013.146 Full Text Advertisement Oncogenesis wants to publish YOUR paper. Oncogenesis is indexed in PubMed, PubMed Central, and the Directory of Open Access Journals, ensuring maximum discoverability of your research. Author also benefit from:  - Open access - Fast publication times - Easy online submission process - High exposure through Nature.com  Submit your paper today! Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.